The present invention provides β3-adrenergic receptor agonists of structural Formula (I) as well as pharmaceutical formulations thereof and methods for treating β3-adrenergic receptor-mediated diseases, conditions, or disorders using
-
Page/Page column 17
(2010/11/30)
More Articles about upstream products of 595544-45-9